Major histocompatibility complex class I proteins in brain development and plasticity

[1]  B. Barres,et al.  The complement system: an unexpected role in synaptic pruning during development and disease. , 2012, Annual review of neuroscience.

[2]  Yi-Ping Jin,et al.  Major histocompatibility complex class I molecules modulate embryonic neuritogenesis and neuronal polarization , 2012, Journal of Neuroimmunology.

[3]  Ben A. Barres,et al.  Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner , 2012, Neuron.

[4]  W. Freeman,et al.  Neuroglial Expression of the MHCI Pathway and PirB Receptor Is Upregulated in the Hippocampus with Advanced Aging , 2012, Journal of Molecular Neuroscience.

[5]  C. Shatz,et al.  Neuroprotection from Stroke in the Absence of MHCI or PirB , 2012, Neuron.

[6]  Zhongming Zhao,et al.  A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC region with schizophrenia , 2011, Journal of Medical Genetics.

[7]  R. Liblau,et al.  Neurons are MHC Class I-Dependent Targets for CD8 T Cells upon Neurotropic Viral Infection , 2011, PLoS pathogens.

[8]  A. Sawa,et al.  Altered MHC class I expression in dorsolateral prefrontal cortex of nonsmoker patients with schizophrenia , 2011, Neurosciences research.

[9]  B. Kirkpatrick,et al.  Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects , 2011, Biological Psychiatry.

[10]  Chris P. Ponting,et al.  A Transcriptomic Atlas of Mouse Neocortical Layers , 2011, Neuron.

[11]  T. Yamashita,et al.  Myelin suppresses axon regeneration by PIR‐B/SHP‐mediated inhibition of Trk activity , 2011, The EMBO journal.

[12]  A. McAllister,et al.  MHCI negatively regulates synapse density during the establishment of cortical connections , 2011, Nature Neuroscience.

[13]  C. Evans,et al.  A Potential Role for Shed Soluble Major Histocompatibility Class I Molecules as Modulators of Neurite Outgrowth , 2011, PloS one.

[14]  V. Edgerton,et al.  Transgenic mice with enhanced neuronal major histocompatibility complex class I expression recover locomotor function better after spinal cord injury , 2011, Journal of neuroscience research.

[15]  I. Hertz-Picciotto,et al.  Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders , 2011, Journal of Neuroimmunology.

[16]  Alan S. Brown,et al.  Maternal infection and schizophrenia: implications for prevention. , 2011, Schizophrenia bulletin.

[17]  Jide Tian,et al.  Enhanced neuronal expression of major histocompatibility complex class I leads to aberrations in neurodevelopment and neurorepair , 2011, Journal of Neuroimmunology.

[18]  Paula Krakowiak,et al.  Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome , 2011, Brain, Behavior, and Immunity.

[19]  Christina Schlumbohm,et al.  Activity-dependent regulation of MHC class I expression in the developing primary visual cortex of the common marmoset monkey , 2011, Behavioral and Brain Functions.

[20]  C. M. Davenport,et al.  MHC class I modulates NMDA receptor function and AMPA receptor trafficking , 2010, Proceedings of the National Academy of Sciences.

[21]  S. Cullheim,et al.  Classic Major Histocompatibility Complex Class I Molecules: New Actors at the Neuromuscular Junction , 2010, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[22]  T. Yamashita,et al.  Paired immunoglobulin-like receptor B knockout does not enhance axonalregeneration or locomotor recovery after spinal cord injury , 2010, Neuroscience Research.

[23]  R. Giger,et al.  Oligodendrocyte-Myelin Glycoprotein and Nogo Negatively Regulate Activity-Dependent Synaptic Plasticity , 2010, The Journal of Neuroscience.

[24]  A. McAllister,et al.  MHC class I molecules are present both pre- and postsynaptically in the visual cortex during postnatal development and in adulthood , 2010, Proceedings of the National Academy of Sciences.

[25]  P. Ashwood,et al.  Immune dysfunction in autism: A pathway to treatment , 2010, Neurotherapeutics.

[26]  B. Stevens,et al.  Synapse elimination during development and disease: immune molecules take centre stage. , 2010, Biochemical Society transactions.

[27]  M. Crair,et al.  The Immune Protein CD3ζ Is Required for Normal Development of Neural Circuits in the Retina , 2010, Neuron.

[28]  Johannes J. Letzkus,et al.  Dendritic Synapse Location and Neocortical Spike-Timing-Dependent Plasticity , 2010, Front. Syn. Neurosci..

[29]  C. Evans,et al.  Neurons Preferentially Respond to Self-MHC Class I Allele Products Regardless of Peptide Presented , 2009, The Journal of Immunology.

[30]  Kristina D. Micheva,et al.  Classical MHCI Molecules Regulate Retinogeniculate Refinement and Limit Ocular Dominance Plasticity , 2009, Neuron.

[31]  Benjamin E. Deverman,et al.  Cytokines and CNS Development , 2009, Neuron.

[32]  A. Kimberley McAllister,et al.  Breaking Boundaries in Neural-Immune Interactions , 2009, Neuron.

[33]  C. Shatz,et al.  MHC Class I: An Unexpected Role in Neuronal Plasticity , 2009, Neuron.

[34]  L. Boulanger,et al.  Immune Proteins in Brain Development and Synaptic Plasticity , 2009, Neuron.

[35]  Pall I. Olason,et al.  Common variants conferring risk of schizophrenia , 2009, Nature.

[36]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[37]  Jianxin Shi,et al.  Common variants on chromosome 6p22.1 are associated with schizophrenia , 2009, Nature.

[38]  C. Shatz,et al.  H2-Kb and H2-Db regulate cerebellar long-term depression and limit motor learning , 2009, Proceedings of the National Academy of Sciences.

[39]  Y. Liou,et al.  Association study of HLA-A gene and schizophrenia in Han Chinese from Taiwan , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[40]  Paula Krakowiak,et al.  Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes , 2008, Journal of Neuroimmunology.

[41]  C. Shatz,et al.  PirB is a Functional Receptor for Myelin Inhibitors of Axonal Regeneration , 2008, Science.

[42]  P. Cresswell,et al.  Regulation of MHC class I assembly and peptide binding. , 2008, Annual review of cell and developmental biology.

[43]  J. Strominger,et al.  The killer's kiss: the many functions of NK cell immunological synapses. , 2008, Current opinion in cell biology.

[44]  Eric O Long.  Negative signaling by inhibitory receptors: the NK cell paradigm , 2008, Immunological reviews.

[45]  J. Mariani,et al.  Normal adult climbing fiber monoinnervation of cerebellar Purkinje cells in mice lacking MHC class I molecules , 2008, Developmental neurobiology.

[46]  P. Naveilhan,et al.  The signaling adaptor protein CD3zeta is a negative regulator of dendrite development in young neurons. , 2008, Molecular biology of the cell.

[47]  J. Yewdell,et al.  Cutting Edge: MHC Class I–Ly49 Interaction Regulates Neuronal Function , 2008, The Journal of Immunology.

[48]  R. Mariuzza,et al.  Cis interactions of immunoreceptors with MHC and non-MHC ligands , 2008, Nature Reviews Immunology.

[49]  I. Kissin,et al.  Persistent changes in spinal cord gene expression after recovery from inflammatory hyperalgesia: A preliminary study on pain memory , 2008, BMC Neuroscience.

[50]  P. Mombaerts,et al.  Expression of Nonclassical Class I Major Histocompatibility Genes Defines a Tripartite Organization of the Mouse Vomeronasal System , 2008, The Journal of Neuroscience.

[51]  S. Cullheim,et al.  MHC class I expression and synaptic plasticity after nerve lesion , 2008, Brain Research Reviews.

[52]  Y. Xing,et al.  A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.

[53]  Julie Miralvès,et al.  High Levels of MeCP2 Depress MHC Class I Expression in Neuronal Cells , 2007, PloS one.

[54]  John D. Lambris,et al.  The Classical Complement Cascade Mediates CNS Synapse Elimination , 2007, Cell.

[55]  P. Patterson,et al.  Maternal Effects on Schizophrenia Risk , 2007, Science.

[56]  M. Chez,et al.  Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. , 2007, Pediatric neurology.

[57]  Masahiko Watanabe,et al.  CD3 and Immunoglobulin G Fc Receptor Regulate Cerebellar Functions , 2007, Molecular and Cellular Biology.

[58]  Carla J. Shatz,et al.  Regulation of CNS synapses by neuronal MHC class I , 2007, Proceedings of the National Academy of Sciences.

[59]  S. Bauer,et al.  The neuropoietic cytokine family in development, plasticity, disease and injury , 2007, Nature Reviews Neuroscience.

[60]  G. Leclercq,et al.  Interactions of Ly49 Family Receptors with MHC Class I Ligands in trans and cis1 , 2007, The Journal of Immunology.

[61]  C. Shatz,et al.  PirB Restricts Ocular-Dominance Plasticity in Visual Cortex , 2006, Science.

[62]  R. Zanon,et al.  MHC I upregulation influences astroglial reaction and synaptic plasticity in the spinal cord after sciatic nerve transection , 2006, Experimental Neurology.

[63]  Adele Cutler,et al.  The association and linkage of the HLA-A2 class I allele with autism. , 2006, Human immunology.

[64]  Jareen Meinzen-Derr,et al.  Elevated cytokine levels in children with autism spectrum disorder , 2006, Journal of Neuroimmunology.

[65]  T. Hensch.  Critical period plasticity in local cortical circuits , 2005, Nature Reviews Neuroscience.

[66]  E. Kandel,et al.  Gene Expression Profiling of Facilitated L-LTP in VP16-CREB Mice Reveals that BDNF Is Critical for the Maintenance of LTP and Its Synaptic Capture , 2005, Neuron.

[67]  Eric O Long,et al.  Expression of a killer cell receptor-like gene in plastic regions of the central nervous system , 2005, Journal of Neuroimmunology.

[68]  A. Zimmerman,et al.  Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.

[69]  T. Hökfelt,et al.  A role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[70]  M. Bear,et al.  LTP and LTD An Embarrassment of Riches , 2004, Neuron.

[71]  Carla J. Shatz,et al.  Immune signalling in neural development, synaptic plasticity and disease , 2004, Nature Reviews Neuroscience.

[72]  J. Zimmer,et al.  Cis association of Ly49A with MHC class I restricts natural killer cell inhibition , 2004, Nature Immunology.

[73]  S. Nelson,et al.  Homeostatic plasticity in the developing nervous system , 2004, Nature Reviews Neuroscience.

[74]  C. Shatz,et al.  Expression of T cell receptor βlocus in central nervous system neurons , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[75]  C. Dulac,et al.  Functional Expression of Murine V2R Pheromone Receptors Involves Selective Association with the M10 and M1 Families of MHC Class Ib Molecules , 2003, Cell.

[76]  J. Darnell,et al.  Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome , 2001, Cell.

[77]  C. Shatz,et al.  Functional requirement for class I MHC in CNS development and plasticity. , 2000, Science.

[78]  H Nawa,et al.  Cytokine and growth factor involvement in schizophrenia—support for the developmental model , 2000, Molecular Psychiatry.

[79]  P. Bjorkman,et al.  Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor , 2000, Nature.

[80]  J. Stagsted.  Journey beyond immunology. Regulation of receptor internalization by major histocompatibility complex class I (MHC‐I) and effect of peptides derived from MHC‐I , 1998, APMIS. Supplementum.

[81]  C. Shatz,et al.  Regulation of Class I MHC Gene Expression in the Developing and Mature CNS by Neural Activity , 1998, Neuron.

[82]  S. Cullheim,et al.  Expression of MHC Class I and β2-Microglobulin in Rat Spinal Motoneurons: Regulatory Influences by IFN-Gamma and Axotomy , 1998, Experimental Neurology.

[83]  E. Thorsby,et al.  Invited anniversary review: HLA associated diseases. , 1997, Human immunology.

[84]  H. Neumann,et al.  Major Histocompatibility Complex (MHC) Class I Gene Expression in Single Neurons of the Central Nervous System: Differential Regulation by Interferon (IFN)-γ and Tumor Necrosis Factor (TNF)-α , 1997, The Journal of experimental medicine.

[85]  T. Nagata,et al.  IFN-γ induces expression of MHC class I molecules in adult mouse dorsal root ganglion neurones , 1996 .

[86]  C. Shatz,et al.  Synaptic Activity and the Construction of Cortical Circuits , 1996, Science.

[87]  L. Mucke,et al.  Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo , 1995, The Journal of experimental medicine.

[88]  H. Neumann,et al.  Induction of MHC class I genes in neurons. , 1995, Science.

[89]  A. Goldstein,et al.  Regulation of receptor internalization by the major histocompatibility complex class I molecule. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[90]  S. Demaria,et al.  Soluble beta 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. , 1994, The Journal of biological chemistry.

[91]  S. Satoh,et al.  Inhibition of internalization of glucose transporters and IGF-II receptors. Mechanism of action of MHC class I-derived peptides which augment the insulin response in rat adipose cells. , 1993, The Journal of biological chemistry.

[92]  J. Olefsky,et al.  Effect of a major histocompatibility complex class I peptide on insulin-like growth factor-I receptor internalization and biological signaling. , 1993, Endocrinology.

[93]  D. McFarlin,et al.  Cell type‐specific regulation of major histocompatibility complex (MHC) Class I gene expression in astrocytes, oligodendrocytes, and neurons , 1993, Glia.

[94]  D. McFarlin,et al.  Regulation of MHC class I and beta 2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes. , 1993, Journal of immunology.

[95]  L. Mucke,et al.  Viral persistence in neurons explained by lack of major histocompatibility class I expression. , 1991, Science.

[96]  A. Abbas,et al.  Cellular and Molecular Immunology , 1991 .

[97]  G. Reaven,et al.  Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen , 1990, Cell.

[98]  E. Ritvo,et al.  Autism and shared parental HLA antigens. , 1985, Journal of the American Academy of Child Psychiatry.

[99]  E. Obberghen,et al.  Immunoprecipitation of insulin receptors by antibodies against Class 1 antigens of the murine H‐2 major histocompatibility complex , 1983, FEBS letters.

[100]  G. Stubbs.  SHARED PARENTAL HLA ANTIGENS AND AUTISM , 1981, The Lancet.

[101]  James B. Murphy,et al.  CONDITIONS DETERMINING THE TRANSPLANTABILITY OF TISSUES IN THE BRAIN , 1923, The Journal of experimental medicine.

[102]  Jerzy K. Kulski,et al.  The HLA genomic loci map: expression, interaction, diversity and disease , 2009, Journal of Human Genetics.

[103]  K. P. Murphy,et al.  Janeway's immunobiology , 2007 .

[104]  S. Segal,et al.  Non-immune functions of MHC class I glycoproteins in normal and malignant cells. , 2004, Folia biologica.

[105]  E. Ling,et al.  Expression of major histocompatibility complex antigens and CR3 complement receptors in activated microglia following an injection of ricin into the sciatic nerve in rats. , 1992, Histology and histopathology.